Dr. Karen T. Tashima, MD

Dr. Tashima practices at Family Health Care Center at SSTAR in Fall River, Massachusetts.

Dr. Tashima's NPI, 1396740551, was assigned on June 15, 2005. Dr. Tashima graduated from Columbia University College of Physicians and Surgeons in 1988. Dr. Tashima holds Rhode Island license MD08951.

Dr. Tashima's primary practice is Family Health Care Center at SSTAR, at 386 Stanley St, Fall River, MA 02720. The practice phone is (508) 679-5222.

Dr. Tashima's primary practice is Family Health Care Center at SSTAR in Fall River, Massachusetts. Dr. Tashima is also affiliated with Charlton Memorial Hospital. The medical group on file is Brown Health Medical Group. Dmand AI also links Dr. Tashima to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account. Dr. Tashima's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tashima practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Tashima's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Tashima is licensed in Rhode Island.

CMS data shows 99 Medicare services from Dr. Tashima across 3 procedure codes in 2024, for 69 Medicare patients. Medicare paid $9,704 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Tashima in 2024. The largest group is 75 to 84, with 23 patients. 75% of them have arthritis, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tashima's median patient age at 61, with 41% women.

In 2024, Dr. Tashima wrote 1,723 Medicare Part D claims for 93 patients. 53% of them were for generic drugs. CMS names the drug for 1,468 of them, across 42 drugs with 11 or more claims each, at $2,825,412 in total drug cost. In 2023, CMS named 1,393 claims across 39 drugs.

Dr. Tashima accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 40 papers to Dr. Tashima, published from 2011 to 2025. 2015 was the busiest year, with 6. The most frequent topics are HIV Infections, CD4 Lymphocyte Count and HIV-1. Dr. Tashima has published most often in AIDS Behav. Dr. Tashima's most frequent co-authors are Ronald L. Cohen, MD, Adam M. Woods, MD and Curt G. Beckwith, MD.

CMS Open Payments shows 32 general payments to Dr. Tashima from 5 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 75% of the total. Gilead Sciences, Inc. paid the most, $8,994. It also lists 15 research payments totaling $1,447 in 2019.

Dr. Tashima graduated from Columbia University College of Physicians and Surgeons in 1988.